Seeing Eye to Eye:
An Ophthalmology-Primary Care Collaboration Emphasizing the Importance of Screening and Early Diagnosis of Retinopathy in Patients with Diabetes
Post-Test/Evaluation

Questions marked with a * are required
40%
Contact Information
Credentials/Degree (MD, DO, etc.)
Date of  Participation
Maria is a 43-year-old Hispanic female with a history of type 2 diabetes diagnosed 4 years ago.  She has moved frequently for work during the last 3 years and has not had any routine diabetes follow-up in this time span. Her fingerstick blood sugar levels typically range between 150-200 mg/dL. Maria now presents to re-establish care. When should she be referred for a screening dilated eye exam?
How effective is timely treatment of diabetic retinopathy (DR) in preventing severe vision loss?
During her visit, Maria reports that she travels frequently for work, so keeping scheduled appointments is difficult. Which of the following could be done to best help Maria overcome barriers to retinopathy screening?
How does vascular endothelial growth factor (VEGF) contribute to the pathophysiology of DR?
Maria underwent in-office retinal photography which identified severe nonproliferative DR with concurrent center-involved macular edema in her right eye and moderate nonproliferative DR in her left eye. Her visual acuity was 20/40 in her right eye and 20/25 in her left eye. What would be the next best step in management?
What is your job role?
What is your type of practice?
How many years have you been in practice?
Please estimate the number of patients with diabetic retinopathy (DR) and/or diabetic macular edema (DME) that you provide for weekly:
Powered by QuestionPro